DCT Tracker update: decentralised clinical trials to reach new peak
Clinical Trials Arena updates its exclusive DCT tracker and projects record trial decentralisation uptake after a minor respite in 2022.
Farewell EudraCT: all trial applications must now be submitted through EMA’s new portal
Mapping endpoints: building gene therapy trials for the future
Predictive analytics in drug development: state of play
Inclusive drugs: designing clinical trials for the pregnant population
Five gene therapy trial readouts to watch in the first half of 2023
Analysis
View More
Subscribe to our Newsletter
Get industry leading news, data and analysis delivered to your inbox
Themes
View MoreGreenLight receives Rwanda FDA approval for Covid-19 mRNA vaccine trial
The Phase I/II clinical trial will evaluate the safety and immunogenicity of the vaccine.
More themes
Insights
View MoreWho’s hiring who? Hiring activity related to social responsibility increased by 10% in the pharmaceutical industry in Q3 2022
The global pharmaceutical industry experienced a 10% rise in new job postings related to social responsibility in Q3 2022 compared…
More Insights
Who’s hiring who? Hiring activity related to artificial intelligence increased by 7% in the pharmaceutical industry in Q3 2022
Who’s hiring who? Hiring activity related to cloud decreased by 8% in the pharmaceutical industry in Q3 2022
Who’s hiring who? Hiring activity related to cybersecurity increased by 30% in the pharmaceutical industry in Q3 2022
Who’s hiring who? Hiring activity related to environmental sustainability decreased by 2% in the pharmaceutical industry in Q3 2022
Buyer's Guides
View More
Digital Magazine
View MorePharma Technology Focus Magazine
Pharma Technology Focus is our digital magazine, free to read online on all devices. Click the magazine cover to read the latest issue. You can subscribe for free to have each new issue delivered to your inbox.
Dyadic initiates subject dosing in Phase I trial of Covid-19 booster
Tevogen Bio reports positive data from Covid-19 T cell therapy trial
Cyrano to initiate Phase II trial of nasal spray therapy for Hyposmia
Shionogi commences Phase I/II/III and Phase III trials of Covid-19 vaccine